Oric Pharmaceuticals (ORIC)

• Market cap: $1.43B
• 1 day: 0.15%
• 5 days: 5.69%
• 1 month: 31.45%
• 3 months: 55.72%
• 6 months: 34.28%
• Year to date: 68.3%
• 1 year: 44.43%
• 5 years: -28.2%
• 10 years: -46.64%
• Sector: Healthcare
• Industry: Biotechnology

About: ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Employees: 111